Emergency Medicine Myths: Epinephrine in Cardiac Arrest

Brit Long, Alex Koyfman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Sudden cardiac arrest accounts for approximately 15% of deaths in developed nations, with poor survival rate. The American Heart Association states that epinephrine is reasonable for patients with cardiac arrest, though the literature behind its use is not strong. Objective: To review the evidence behind epinephrine for cardiac arrest. Discussion: Sudden cardiac arrest causes over 450,000 deaths annually in the United States. The American Heart Association recommends epinephrine may be reasonable in patients with cardiac arrest, as part of Advanced Cardiac Life Support. This recommendation is partly based on studies conducted on dogs in the 1960s. High-dose epinephrine is harmful and is not recommended. Epinephrine may improve return of spontaneous circulation, but does not improve survival to discharge or neurologic outcome. Literature suggests that three phases of resuscitation are present: electrical, circulatory, and metabolic. Epinephrine may improve outcomes in the circulatory phase prior to 10 min post arrest, though further study is needed. Basic Life Support measures including adequate chest compressions and early defibrillation provide the greatest benefit. Conclusions: Epinephrine may improve return of spontaneous circulation, but it does not improve survival to discharge or neurologic outcome. Timing of epinephrine may affect patient outcome, but Basic Life Support measures are the most important aspect of resuscitation and patient survival.

Original languageEnglish (US)
JournalJournal of Emergency Medicine
DOIs
StateAccepted/In press - Dec 6 2016

Fingerprint

Emergency Medicine
Heart Arrest
Epinephrine
Sudden Cardiac Death
Resuscitation
Nervous System
Survival
Advanced Cardiac Life Support
Developed Countries
Thorax
Survival Rate
Dogs

Keywords

  • Advanced Cardiac Life Support
  • Basic Life Support
  • Cardiac arrest
  • Epinephrine
  • Pulseless electrical activity
  • Ventricular fibrillation

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Emergency Medicine Myths : Epinephrine in Cardiac Arrest. / Long, Brit; Koyfman, Alex.

In: Journal of Emergency Medicine, 06.12.2016.

Research output: Contribution to journalArticle

@article{6ddb7292ba5445a9bbb3ab7443db7bf4,
title = "Emergency Medicine Myths: Epinephrine in Cardiac Arrest",
abstract = "Background: Sudden cardiac arrest accounts for approximately 15{\%} of deaths in developed nations, with poor survival rate. The American Heart Association states that epinephrine is reasonable for patients with cardiac arrest, though the literature behind its use is not strong. Objective: To review the evidence behind epinephrine for cardiac arrest. Discussion: Sudden cardiac arrest causes over 450,000 deaths annually in the United States. The American Heart Association recommends epinephrine may be reasonable in patients with cardiac arrest, as part of Advanced Cardiac Life Support. This recommendation is partly based on studies conducted on dogs in the 1960s. High-dose epinephrine is harmful and is not recommended. Epinephrine may improve return of spontaneous circulation, but does not improve survival to discharge or neurologic outcome. Literature suggests that three phases of resuscitation are present: electrical, circulatory, and metabolic. Epinephrine may improve outcomes in the circulatory phase prior to 10 min post arrest, though further study is needed. Basic Life Support measures including adequate chest compressions and early defibrillation provide the greatest benefit. Conclusions: Epinephrine may improve return of spontaneous circulation, but it does not improve survival to discharge or neurologic outcome. Timing of epinephrine may affect patient outcome, but Basic Life Support measures are the most important aspect of resuscitation and patient survival.",
keywords = "Advanced Cardiac Life Support, Basic Life Support, Cardiac arrest, Epinephrine, Pulseless electrical activity, Ventricular fibrillation",
author = "Brit Long and Alex Koyfman",
year = "2016",
month = "12",
day = "6",
doi = "10.1016/j.jemermed.2016.12.020",
language = "English (US)",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Emergency Medicine Myths

T2 - Epinephrine in Cardiac Arrest

AU - Long, Brit

AU - Koyfman, Alex

PY - 2016/12/6

Y1 - 2016/12/6

N2 - Background: Sudden cardiac arrest accounts for approximately 15% of deaths in developed nations, with poor survival rate. The American Heart Association states that epinephrine is reasonable for patients with cardiac arrest, though the literature behind its use is not strong. Objective: To review the evidence behind epinephrine for cardiac arrest. Discussion: Sudden cardiac arrest causes over 450,000 deaths annually in the United States. The American Heart Association recommends epinephrine may be reasonable in patients with cardiac arrest, as part of Advanced Cardiac Life Support. This recommendation is partly based on studies conducted on dogs in the 1960s. High-dose epinephrine is harmful and is not recommended. Epinephrine may improve return of spontaneous circulation, but does not improve survival to discharge or neurologic outcome. Literature suggests that three phases of resuscitation are present: electrical, circulatory, and metabolic. Epinephrine may improve outcomes in the circulatory phase prior to 10 min post arrest, though further study is needed. Basic Life Support measures including adequate chest compressions and early defibrillation provide the greatest benefit. Conclusions: Epinephrine may improve return of spontaneous circulation, but it does not improve survival to discharge or neurologic outcome. Timing of epinephrine may affect patient outcome, but Basic Life Support measures are the most important aspect of resuscitation and patient survival.

AB - Background: Sudden cardiac arrest accounts for approximately 15% of deaths in developed nations, with poor survival rate. The American Heart Association states that epinephrine is reasonable for patients with cardiac arrest, though the literature behind its use is not strong. Objective: To review the evidence behind epinephrine for cardiac arrest. Discussion: Sudden cardiac arrest causes over 450,000 deaths annually in the United States. The American Heart Association recommends epinephrine may be reasonable in patients with cardiac arrest, as part of Advanced Cardiac Life Support. This recommendation is partly based on studies conducted on dogs in the 1960s. High-dose epinephrine is harmful and is not recommended. Epinephrine may improve return of spontaneous circulation, but does not improve survival to discharge or neurologic outcome. Literature suggests that three phases of resuscitation are present: electrical, circulatory, and metabolic. Epinephrine may improve outcomes in the circulatory phase prior to 10 min post arrest, though further study is needed. Basic Life Support measures including adequate chest compressions and early defibrillation provide the greatest benefit. Conclusions: Epinephrine may improve return of spontaneous circulation, but it does not improve survival to discharge or neurologic outcome. Timing of epinephrine may affect patient outcome, but Basic Life Support measures are the most important aspect of resuscitation and patient survival.

KW - Advanced Cardiac Life Support

KW - Basic Life Support

KW - Cardiac arrest

KW - Epinephrine

KW - Pulseless electrical activity

KW - Ventricular fibrillation

UR - http://www.scopus.com/inward/record.url?scp=85011349983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011349983&partnerID=8YFLogxK

U2 - 10.1016/j.jemermed.2016.12.020

DO - 10.1016/j.jemermed.2016.12.020

M3 - Article

C2 - 28174032

AN - SCOPUS:85011349983

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

ER -